Delivering Breakthrough Therapeutics to Patients Globally
-
In Global
- With World-class Discovery and Development Teams
-
For Global
- To provide breakthrough Therapies for Patients Worldwide
-
Innovation for Cures
- Developing innovative biologics for patients globally
Core Strengths of Biosion
Our Teams
Biosion has a world-class expertise in preclinical and early development to drive our portfolio to clinical success.
Pipeline
Our pipeline of product candidates are those we have commercialization or other important rights in the U.S. and globally.
The Mission of Biosion
To discover and develop innovative biologics through the synergy of great science, cutting edge technologies and superior craftsmanship for patients worldwide.
News & Events
December 10, 2020
Biosion, Inc. Raises ¥200M RMB Financing to Support Further Global Development of Its Innovative Pipeline
October 18, 2021
Biosion, Inc. Appoints Yao-Yao Zhu, M.D., Ph.D., Head of Global Regulatory Affairs
November 12, 2021
Biosion, Inc. and Celldex present positive preclinical data at SITC 2021. CDX-585 is the first compound from Celldex’s research and collaboration agreement with Biosion, Inc. and combines Celldex’s ILT4 mAb with Biosion’s PD-1 mAb.
